Marlana Orloff

Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma

Paul Nathan, Jessica C. Hassel, Piotr Rutkowski et al. · New England Journal of Medicine · 2021 · 806 citations · Full text

Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 study

Jason Chesney, Karl D. Lewis, Harriet M. Kluger et al. · Journal for ImmunoTherapy of Cancer · 2022 · 268 citations · Full text

Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma

Jessica C. Hassel, Sophie Piperno‐Neumann, Piotr Rutkowski et al. · New England Journal of Medicine · 2023 · 213 citations · Full text

PD-L1 Expression in Tumor Metastasis is Different Between Uveal Melanoma and Cutaneous Melanoma

Asad Javed, David Arguello, Curtis Johnston et al. · Immunotherapy · 2017 · 81 citations · Full text

Adjuvant Sunitinib in High-Risk Patients with Uveal Melanoma

Matías E. Valsecchi, Marlana Orloff, Rino Sato et al. · Ophthalmology · 2017 · 60 citations

Medicine, Photocarcinogenesis, Melanoma +3